Centralized care for the management of Barrett’s esophagus: the path forward or just an academic dream?

Arvind J. Trindade

doi:10.1055/a-1843-9682

Endoscopy, Table of Contents

Endoscopy 2022; 54(10): 945-947
DOI: 10.1055/a-1843-9682

Editorial

Centralized care for the management of Barrett’s esophagus: the path forward or just an academic dream?

Referring to Nieuwenhuis EA et al. p. 936–944

Arvind J. Trindade

¹Division of Gastroenterology, Long Island Jewish Medical Center, Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, New Hyde Park, New York, United States

²Institute of Health System Science, Feinstein Institutes for Medical Research, Manhasset, New York, United States

› Author Affiliations

Abstract

Full Text

References

References
1 Visrodia K, Singh S, Krishnamoorthi R. et al. Magnitude of missed esophageal adenocarcinoma after Barrett’s esophagus diagnosis: a systematic review and meta-analysis. Gastroenterology 2016; 150: 599-607
2 Sharma P, Katzka DA, Gupta N. et al. Quality indicators for the management of Barrett’s esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association symposium. Gastroenterology 2015; 149: 1599-1606
3 Nieuwenhuis EA, van Munster SN, Curvers WL. et al. Impact of expert center endoscopic assessment of confirmed low grade dysplasia in Barrett’s esophagus diagnosed in community hospitals. Endoscopy 2022; 54: 936-944
4 Tsoi EH, Mahindra P, Cameron G. et al. Barrett’s esophagus with low-grade dysplasia: high rate of upstaging at Barrett’s esophagus referral units suggests progression rates may be overestimated. Gastrointest Endosc 2021; 94: 902-908
5 Schölvinck DW, Van Der Meulen K, Bergman JJGHM. et al. Detection of lesions in dysplastic Barrett’s esophagus by community and expert endoscopists. Endoscopy 2017; 49: 113-120
6 Pasricha S, Cotton C, Hathorn KE. et al. Effects of the learning curve on efficacy of radiofrequency ablation for Barrett’s esophagus. Gastroenterology 2015; 149: 890-896
7 Fudman DI, Lightdale CJ, Poneros JM. et al. Positive correlation between endoscopist radiofrequency ablation volume and response rates in Barrett’s esophagus. Gastrointest Endosc 2014; 80: 71-77
8 Roumans CAM, Van Der Bogt RD, Steyerberg EW. et al. Adherence to recommendations of Barrett’s esophagus surveillance guidelines: a systematic review and meta-analysis. Endoscopy 2020; 52: 17-28
9 Weusten B, Bisschops R, Coron E. et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2017; 49: 191-198
10 Nederlandse Vereniging van Maag-Darm-Leverartsen. Richtlijn Barrett-oesofagus. In Dutch.. IKNL; 2018: 1-71 https://www.mdl.nl/sites/www.mdl.nl/files/richlijnen/Richtlijnen%20Barrett%20oesofagus%20-%20jan%202018%20-%20tbv%20website.pdf
11 Fitzgerald RC, di Pietro M, Ragunath K. et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut 2014; 63: 7-42
12 Sharma P, Shaheen NJ, Katzka D. et al. AGA clinical practice update on endoscopic treatment of Barrett’s esophagus with dysplasia and/or early cancer: expert review. Gastroenterology 2020; 158: 760-769